|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2019
12 months to Sep 30, 2019
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Intangible asset impairment | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income, net | |||||
| Financial expense, net | |||||
| Foreign currency loss | |||||
| Loss before income tax benefit | |||||
| Income tax benefit | |||||
| Net loss | |||||
| Net loss per common share, basic and diluted | |||||
| Weighted-average shares used in computing net loss per common share, basic and diluted | |||||
| Net loss per common share, basic | |||||
| Net loss per common share, diluted | |||||
| Weighted-average shares used in computing net loss per common share, basic | |||||
| Weighted-average shares used in computing net loss per common share,diluted | |||||
Loading...